2 completed, 1 terminated. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Speech Therapy: new trials by email Literature Review of Speech Therapy trials Research Report on Speech Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders tDCS or Transcranial Direct Current Stimulation, Risperidone, Sham tDCS - Attention, Visual Perceptual Weakness | Phase 1 / Phase 2 | Completed | Spanish Foundation for Neurometrics Development | 180 | 2024-04-01 | 2026-09-10 |
| Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia Famotidine, Speech Language Therapy - Laryngomalacia, Gastro Esophageal Reflux | Phase 1 / Phase 2 | Terminated | Reema Padia | 65 | 2020-11-18 | 2025-07-20 |
| The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist Speech Therapy - Autism, Asperger Syndrome | Phase 1 / Phase 2 | Completed | Federal University of São Paulo | 11 | 2006-03-01 | 2008-08-01 |
Asperger Syndrome (1) · Autistic Disorder (1) · Communication Disorders (1) · Gastroesophageal Reflux (1) · Laryngomalacia (1) · Social Behavior (1)
Federal University of São Paulo (1) · Reema Padia (1) · Spanish Foundation for Neurometrics Development (1)
United States (2) · Brazil (1)
Ana Carina Tamanaha, Student (1) · Reema Padia, MD (1)
PMID 25468234, PMID 27173384, PMID 29625151, PMID 33578648, PMID 33658971, PMID 33823927, PMID 35734582, PMID 37445385, PMID 40762274